1 Day
Source:
البيان
Dubai Team Stops Seizures
A medical team in Dubai succeeded in stopping seizures in infant Adnan, who had been experiencing around 110 seizures a day, within 30 minutes of his first dose of the experimental treatment ABS-1230 on September 14, 2026, after seven previous treatment approaches had failed. The drug was made available through a “compassionate use” pathway, through joint efforts by the Emirates Drug Establishment, the Dubai Health Authority, and King’s College Hospital London–Dubai, after advanced genetic testing identified the cause of the condition and helped select a treatment targeting its underlying mechanism. The child was discharged from hospital on September 21 with no clinical seizures observed. However, the treatment remains under study and has not been approved for commercial use; the response is from a single case and requires follow-up to assess its durability and safety.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)